Trump has begun another trade war. Here's a timeline of how we got here
Canada's leader laments lost friendship with US in town that sheltered stranded Americans after 9/11
Chinese EV giant BYD's fourth-quarter profit leaps 73%
You're an American in another land? Prepare to talk about the why and how of Trump 2.0
Chalk talk: Star power, top teams and No. 5 seeds headline the women's March Madness Sweet 16
Purdue returns to Sweet 16 with 76-62 win over McNeese in March Madness
Preliminary data from the Centers for Disease Control and Prevention reveal that overdose deaths involving fentanyl dropped by 27% nationwide in 2024 compared to the previous year. This marks the first significant decline in fentanyl overdose deaths in decades, offering a hopeful signal that public health interventions may be starting to turn the tide on the nation’s opioid crisis, per the Washington Post article.
Fentanyl, a synthetic opioid up to 50 times stronger than heroin, has been a major driver of overdose deaths. Its potency and low cost have led to widespread contamination of the illicit drug supply, often without users’ knowledge. This made it particularly deadly and difficult to combat. This decline shows more people are getting the support they need in time.
A keystone of these efforts has been the widespread availability of naloxone, the opioid overdose reversal drug. After the FDA’s decision in early 2023 to allow over-the-counter sales of Narcan nasal spray, more Americans could easily obtain naloxone without a prescription. This expanded access has empowered families, friends, and even strangers to intervene immediately when overdoses occur, preventing countless deaths.
“The FDA remains committed to addressing the evolving complexities of the overdose crisis. As part of this work, the agency has used its regulatory authority to facilitate greater access to naloxone by encouraging the development of and approving an over-the-counter naloxone product to address the dire public health need,” FDA Commissioner Robert M. Califf, M.D. said.
Telemedicine has further transformed addiction treatment by making medications for opioid use disorder, such as buprenorphine, more accessible. Since January 2025, healthcare providers have been able to prescribe buprenorphine remotely without requiring an initial in-person visit, a policy that is now permanent, following temporary measures during the COVID-19 pandemic. This change helps overcome barriers like stigma, transportation issues, and provider shortages, especially in rural and underserved communities, according to the United States Drug Enforcement Administration.
“DEA’s goal is to provide telehealth access for needed medications while ensuring patient safety and preventing the diversion of medications into the illicit drug market. We understand the difficulties some patients have accessing medical providers in person, and we want to ease this burden while providing safeguards to keep patients safe,” said DEA Administrator Anne Milgram.
Beyond domestic policy, international cooperation has played a crucial role. President Donald Trump’s efforts to persuade China to ban fentanyl in 2019 led to significant restrictions on the production and export of these substances. The Peterson Institute for International Economics estimates this ban prevented roughly 1,000 fentanyl-related deaths per year by cutting off a major supply channel.
Individual states have also reported promising declines in fentanyl overdose deaths due to targeted efforts. Pennsylvania saw a 31% reduction in 2024, attributed to a mix of naloxone distribution, increased funding for addiction treatment, and harm reduction initiatives such as the availability of fentanyl test strips that allow users to detect the drug in substances before consumption.
Virginia’s fentanyl deaths dropped even more sharply — by 44%. The state’s multifaceted response included public education campaigns, widespread naloxone availability, and distribution of fentanyl test strips. “Our approach stands on four principles: interrupt the drug trade, enhance penalties for drug dealers, educate people about the dangers of fentanyl, and equip them to save the life of someone in crisis,” Gov. Glenn Youngkin said.
Texas experienced a nearly 14% drop in fentanyl deaths, where programs like the Houston Emergency Opioid Engagement System have connected overdose survivors to treatment and support immediately after emergencies. Such programs highlight the value of combining community outreach with medical intervention to prevent repeat overdoses.
Despite the progress, experts caution recent federal funding cuts to opioid intervention programs could stall momentum. Reduced budgets threaten critical services like naloxone distribution and community outreach, risking a reversal of the gains made in combating fentanyl-related deaths.
Also Read:
- US drug overdose deaths saw an unprecedented drop in 2024, but federal cuts could threaten momentum
- US imposes sanctions on top members of the armed wing of a Mexican fentanyl-trafficking cartel
- Trump vows to launch anti-drug ad campaign, designate Mexican cartels as terrorists
- Historic fentanyl bust was enough to kill more than 800,000 people
